Phenotype of severe hemophilia A and plasma levels of risk factors for thrombosis [1]

Journal of Thrombosis and Haemostasis

Volumn 5, Issue 5, 2007, Pages 1062-1064

  van Dijk, K ^a,b   van der Bom, J G ^a,c   Fischer, K ^a,b   de Groot, P G ^b   van den Berg, H M ^a,d  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 8; PROTHROMBIN; VON WILLEBRAND FACTOR;

ADOLESCENT; ADULT; ARTERY THROMBOSIS; ARTHROPATHY; BLOOD CLOT LYSIS; BLOOD CLOTTING; BLOOD CLOTTING FACTOR 5 DEFICIENCY; BLOOD SAMPLING; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; FIBRINOLYSIS; FOLLOW UP; HEMOPHILIA A; HUMAN; INFORMED CONSENT; INTRON; LETTER; MAJOR CLINICAL STUDY; PATIENT SELECTION; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; PROBABILITY; PROTEIN BLOOD LEVEL; RISK FACTOR; SCHOOL CHILD; STATISTICAL SIGNIFICANCE; STUDENT T TEST; THROMBIN TIME; THROMBOSIS; VALIDATION PROCESS; VEIN THROMBOSIS;

ADOLESCENT; ADULT; COHORT STUDIES; HEMOPHILIA A; HUMANS; PHENOTYPE; RISK FACTORS; THROMBOSIS;

EID: 34247876186     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2007.02447.x     Document Type: Letter

References (16)

1. Aledort LM, Haschmeyer RH, Pettersson H A longitudinal study of orthopaedic outcomes for severe factor-VIII-deficient haemophiliacs. J Intern Med 1994; 236: 391-9.
2. Molho P, Rolland N, Lebrun T, Dirat G, Courpied JP, Croughs T, Duprat I, Sultan Y Epidemiological survey of the orthopaedic status of severe haemophilia A and B patients in France. Haemophilia 2000; 6: 23-32.
3. Schramm W, Royal S, Kroner B, Berntorp E, Giangrande P, Ludlam C, Gringeri A, Berger K, Szucs T Clinical outcomes and resource utilization associated with haemophilia care in Europe. Haemophilia 2002; 8: 33-43.
4. Fischer K, Astermark J, van der Bom JG, Ljung R, Berntorp E, Grobbee DE, van den Berg HM Prophylactic treatment for severe haemophilia: comparison of an intermediate-dose to a high-dose regimen. Haemophilia 2002; 8: 753-60.
5. Fischer K, van der Bom JG, Mauser-Bunschoten EP, Roosendaal G, Prejs R, Grobbee DE, van den Berg HM Changes in treatment strategies for severe haemophilia over the last 3 decades: Effects on clotting factor consumption and arthropathy. Haemophilia 2001; 7: 446-52.
6. Van Dijk K, van der Bom JG, Lenting PJ, de Groot PG, Mauser-Bunschoten EP, Roosendaal G, Grobbee DE, van den Berg HM Factor VIII half-life and clinical phenotype of severe hemophilia A. Haematologica 2005; 90: 494-8.
7. Fischer K, van der Bom JG, Prejs R, Mauser-Bunschoten EP, Roosendaal G, Grobbee DE, van den Berg HM Discontinuation of prophylactic therapy in severe haemophilia: Incidence and effects on outcome. Haemophilia 2001; 7: 544-50.
8. Van Dijk K, Fischer K, van der Bom JG, Grobbee DE, van den Berg HM Variability in clinical phenotype of severe haemophilia: The role of the first joint bleed. Haemophilia 2005; 11: 438-43.
9. Lisman T, de Groot PG, Meijers JC, Rosendaal FR Reduced plasma fibrinolytic potential is a risk factor for venous thrombosis. Blood 2005; 105: 1102-5.
10. Fischer K, van Hout BA, van der Bom JG, Grobbee DE, van den Berg HM Association between joint bleeds and Pettersson scores in severe haemophilia. Acta Radiol 2002; 43: 528-32.
11. Grunewald M, Grunewald A, Griesshammer M Paradoxical hyperfibrinolysis is associated with a more intensely haemorrhagic phenotype in severe congenital haemophilia. Haemophilia 2002; 8: 768-75.
12. Siegemund T, Petros S, Siegemund A, Scholz U, Engelmann L Thrombin generation in severe haemophilia A and B: The endogenous thrombin potential in platelet-rich plasma. Thromb Haemost 2003; 90: 781-6.
13. Beltran-Miranda CP, Khan A, Jaloma-Cruz AR, Laffan MA Thrombin generation and phenotypic correlation in haemophilia A. Haemophilia 2005; 11: 326-34.
14. Santagostini E, Mancuso ME, Tripodi A, Chantarangkul V, Clerici M, Sei C, Mannucci P Thrombin generation in severe hemophiliacs with different clinical phenotype. Blood 2006; 108: P1000.
15. Dale GL Coated platelets: An emerging component of the procoagulant response. J Thromb Haemost 2005; 3: 2185-92.
16. Saxena K, Pethe K, Dale GL Coated-platelet levels may explain some variability in clinical phenotype of severe hemophilia. Blood 2006; 108: P1018.